Therefore, we conclude that BAFF inhibition with novel drugs could be promising (Dalakas 2019; Huang et al. 2018; Nakayamada and Tanaka 2016), yet not well-established pathway in autoimmune diseases possibly including also myasthenia gravis. Here, TNFSF13B is linked to autoimmune disease.